Halozyme Therapeutics, Inc. (HALO) Dividend Yield, History & Forecast
Halozyme Therapeutics, Inc. (HALO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Global Select. market capitalization is approximately $7.61B.
Frequently Asked Questions about Halozyme Therapeutics, Inc. (HALO)
Is Halozyme Therapeutics, Inc. a Dividend Aristocrat?▾
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Halozyme Therapeutics, Inc. in?▾
Halozyme Therapeutics, Inc. (HALO) operates in the Healthcare sector, specifically the Biotechnology industry.
